Genmab — Marts 2014
-
det er en kamp der er hård at bekæmpe. Genmab skal jo komme med gode news hver uge fremover bare for at holde den i status quo
-
US Bioteck ser fin ud indtil videre. Kun Genmab som fucker op idag
-
biotekrally nu
-
Genmab efterladt tilbage
-
Købte selv Gilead idag i 69 for 50.000 kr. tror på 20% rebound
-
Ikke afgørende nyt (så vidt jeg kan se ved hurtig læsning) men flot darapræsentation http://files.shareholder.com/downloads/AMDA-KPIBN/3041062188x0x738846/3be363cb-e788-45aa-8f83-fd3bc55a7431/2014 Whistler MM Summit _ Michael Bauer _ CD38 A unique target _ final.pdf
-
http://patents.justia.com/patent/20130345406 min studentereksamen rækker ikke her. Men Genmab ser ud til at arbejde på en helt ny metode til at behandle sygdomme. Gad vide hvornår vi hører nærmere om det.
-
Solsen - de har lige præsenteret det her http://www.genmab.com/duobody/home/news-archive/presentation-on-igg4-biology-and-the-duobody-platform-at-att-2014
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind